Diagnostic Tools for Kala-Azar and Post-Kala-Azar Dermal Leishmaniasis (PKDL)
A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Point-of-Care Diagnostics and Devices".
Deadline for manuscript submissions: closed (31 October 2023) | Viewed by 2128
Special Issue Editors
Interests: diagnostic tools for kala-azar and PKDL; mechanism of immune regulation and drug induced immunomodulation in Indian kala-azar and PKDL; evaluation of vaccination strategies and protein- and DNA-based candidate antigens; studies on immune stimulation pathways by liposomal vaccines; cationic liposome based combination therapy with existing drugs and novel compounds; study of host cell signaling during visceral leishmaniasis; validation of novel drug targets for the treatment of visceral leishmaniasis; development of strategies for cancer targeting by liposomal formulations
Interests: parasitic diseases; tropical diseases; zoonotic diseases; infectious disease epidemiology; infection; immunology; zoonoses; infectious disease transmission; biotechnology; malaria
Special Issue Information
Dear Colleagues,
Leishmaniasis, a parasitic disease, is a public health problem worldwide, with visceral leishmaniasis (VL) or kala-azar being potentially fatal in the absence of treatment. Over the past few years, incredible progress has been achieved with regard to VL control in many endemic areas. The key factors that have impacted this success rely on strategies for early diagnosis and effective treatment. Besides VL, the management of post-kala-azar dermal leishmaniasis (PKDL), generally a sequel to kala-azar, and HIV-VL coinfections remain additional challenges to VL elimination programs. The world after the COVID-19 pandemic is facing novel concerns regarding existing infectious diseases that cause immunocompromised conditions. Therefore, in order to conquer the disease, diagnostic tools could be one of the impactful measures utilized. This Special Issue will focus on several aspects of VL and PKDL diagnosis that are yet to be fully unraveled, along with the inherent limitations and drawbacks of current diagnostics. We welcome authors to contribute to this Special Issue by submitting their original research and review articles relevant to the topic.
Dr. Nahid Ali
Dr. Sarfaraz Ahmad Ejazi
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
